“Earlier reports from The Wall Street Journal were confirmed this week: Apple chief executive Steve Jobs had a liver transplant two months ago at a Tennessee hospital,” Tim Beyers opines for The Motley Fool.
“‘He received a liver transplant because he was the patient with the highest MELD score (Model for End-Stage Liver Disease) of his blood type and, therefore, the sickest patient on the waiting list at the time a donor organ became available. Mr. Jobs is now recovering well and has an excellent prognosis,’ Dr. James D. Eason of Methodist University Hospital Transplant Institute said in a statement,” Beyers writes.
“Someone should pay for hiding material information like this,” Beyers writes. “But it’s not obvious that anyone will — except perhaps for those who bought shares without understanding Jobs’ health status.”
Beyers writes, “I’m an Apple shareholder, and I’ve given Jobs and Apple the benefit of the doubt too many times… Apple has been rotten to the core when it comes to disclosure.”
Full article here.